Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma.
about
Immunotherapy: New Strategies for the Treatment of Gynecologic MalignanciesCurrent Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast CancerImmunotherapy in endometrial cancer - an evolving therapeutic paradigmPOLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial CancerMorphological observation of tumor infiltrating immunocytes in human rectal cancerEnumeration of leukocyte infiltration in solid tumors by confocal laser scanning microscopy.Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.Prognostic impact of lymphocytes in soft tissue sarcomasTumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma.Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomasIncreased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancerCD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breastThe value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma.Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parametersPersistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independentBoosting antitumor responses of T lymphocytes infiltrating human prostate cancers.Overexpression of CD39 and high tumoral CD39⁺/CD8⁺ ratio are associated with adverse prognosis in resectable gastric cancerIncreased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrenceLow density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer.The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patientsTherapeutic cancer vaccines in prostate cancer: the quest for intermediate markers of response.Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma.Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation.A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.Tumor infiltrating regulatory T cells: tractable targets for immunotherapy.Immunologic biomarkers as correlates of clinical response to cancer immunotherapy.Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.Clinical evaluation of systemic and local immune responses in cancer: time for integration.Blessing or curse? Proteomics in granzyme research.Immune reaction and colorectal cancer: friends or foes?Immune biomarkers: how well do they serve prognosis in human cancers?Endometrial adenocarcinoma in spontaneous abortion: two cases and review of the literature.Lymphocytic Infiltration as a Prognostic Factor in Patients With Colon Cancer.T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China's Heilongjiang province.Clinical implications of human leukocyte antigen class I expression in endometrial cancer.High levels of granzyme B expression in invasive cervical carcinoma correlates to poor response to treatment.Tryptase-positive mast cells and CD8-positive T cells in human endometrial cancer.
P2860
Q26770607-421EFC1A-72D0-4BBA-9406-236D25CFC7F5Q26798074-F3F64C50-1C09-4B22-AA0D-17C1B0F467C2Q27020910-0AF255EB-4933-404A-8351-C0E04BF0DB6FQ28260529-067B22BA-578B-462B-B171-45C45113B5ADQ33238645-9F154914-B202-4AB1-A87C-165037C65693Q33251349-C893E94B-F7D1-47BC-A84E-133B2DBEF724Q33671093-6E911D2E-825A-44B9-BE58-ACE060171BBCQ33783092-308C311E-22B5-452C-AF67-CAF151500A37Q33813250-81405573-AE54-422C-977C-8E7FC2D11603Q34011765-FA0F65D6-03CA-4034-9AF2-23FE7DBA6A6FQ34147704-8EBFA381-AF8F-4EBA-97B7-8432E44DC1EFQ34178633-B03C5B56-BA63-46A2-85AA-6D8C0DC6808FQ34396474-60B972C4-C8D1-4ABD-AF94-CB36F2001491Q34590820-C31AD194-954E-45FD-891B-5F82BD040031Q34690824-4AEBC846-C54E-430E-BA45-DB9FF03CB5D4Q34951157-896C86F6-F5D3-4BCC-8943-AB41CB079BECQ36027067-9EFEE74C-AD70-41B0-B06A-BF3604AAA322Q36053040-AF6796DE-558D-4942-9C4F-9E12550EB245Q36403503-936927D4-7FAB-4BD0-8C25-684B0630C917Q36464610-6390202A-22DE-4A79-A2D3-FE7755DE75C7Q36555546-C1759E8B-05E7-4D0C-8092-3B653AE15B82Q36611383-BCC2201F-10E4-4BF4-AC4C-C8F5263DD9C2Q36946671-BCBB9B51-F1D7-4E8A-8D2F-8B62DC8B8958Q37017101-D2A3900F-AD1D-4E96-9B21-CB229CCF1386Q37142426-01F5581A-EF30-4E94-B238-34C51E317678Q37414190-29BA0FCF-490F-4728-87F3-35EFA147C58DQ37729253-2144479A-D835-402D-BE77-4B8996527E19Q37788679-B0F5A137-66E8-44DC-A47B-5A63E291B81DQ37827418-E8C57877-4E07-4847-884E-CAC2538C19F6Q37945304-E3CF14D2-CC75-4862-AF55-2A84C791C99DQ38150174-B734A080-347A-4BA3-8322-E44E0623D0F1Q38200060-EC705304-BB33-4269-8BFB-B11488BAA321Q38254123-4A6A2101-28DA-4FE3-A187-E57A3DFD8B2FQ38262757-E4A296D1-6E91-4AA7-801C-652F23135DF9Q38556694-8C3947E5-58BF-44CA-B298-73BDA87F0A93Q41543620-B6AF57B1-D16A-4D4A-A33A-B4C18880A080Q42254317-5E14CD99-9DB2-4461-9E84-D65017569EF4Q43147365-37E5B230-11EC-46CA-B95D-14FD8FCFBB29Q43514433-5340666C-7FDF-4D3B-AEAE-17A2510060A3Q43549277-417DB119-04A6-4E2D-9555-A4CDC203FAAC
P2860
Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Intratumoral CD8+ T lymphocyte ...... ival in endometrial carcinoma.
@en
Intratumoral CD8+ T lymphocyte ...... ival in endometrial carcinoma.
@nl
type
label
Intratumoral CD8+ T lymphocyte ...... ival in endometrial carcinoma.
@en
Intratumoral CD8+ T lymphocyte ...... ival in endometrial carcinoma.
@nl
prefLabel
Intratumoral CD8+ T lymphocyte ...... ival in endometrial carcinoma.
@en
Intratumoral CD8+ T lymphocyte ...... ival in endometrial carcinoma.
@nl
P2093
P1476
Intratumoral CD8+ T lymphocyte ...... ival in endometrial carcinoma.
@en
P2093
Edmond Sabo
Evgeny Yakirevich
Murray B Resnick
Ofer Lavie
Svetlana Kondratiev
P304
P356
10.1158/1078-0432.CCR-0732-3
P407
P577
2004-07-01T00:00:00Z